论文部分内容阅读
乙肝后肝癌术后抗病毒治疗,可在2年内降低30%的复发率,4年内降低25%的复发率,且不需要巨额医药费用。第二军医大学肝炎肝癌研究课题的这一最新研究成果,在线发表在新一期国际权威癌症杂志、美国《临床肿瘤学杂志》上,并在同期配有述评文章。据悉,全球约有1/3人口曾经或目前被乙型肝炎病毒感染,其中3亿人为慢性乙型肝炎病毒感染者。肝细胞癌占
Post-hepatitis B anti-virus treatment after liver cancer can reduce the recurrence rate by 30% within 2 years, reduce the recurrence rate by 25% within 4 years, and does not require huge medical expenses. The latest research results of the Hepatitis Liver Cancer Research Project of the Second Military Medical University were published online in the new issue of the international authoritative cancer magazine and the American Journal of Clinical Oncology, and were accompanied by review articles during the same period. It is reported that about one third of the world’s population has been or is currently infected with the hepatitis B virus, of whom 300 million are chronic hepatitis B virus infections. Hepatocellular carcinoma accounts for